Steven Bodovitz work email
- Valid
- Valid
- Valid
- Valid
Steven Bodovitz personal email
Steven Bodovitz phone numbers
I have more than 25 years of experience in biotechnology with core expertise in providing clear and timely analyses of markets and strategy. Over the last 12 years, I have focused on new product planning, starting with immuno-oncology and expanding into nephrology, neurology and other therapeutic areas. One of my most notable new product plans led to a significant change in corporate strategy that, in turn, led to a merger, a positive readout in a Phase 2 trial and an acquisition. I also take pride in my versatility to help organizations succeed and grow. I have worked closely with multiple CEOs at small biotech companies and start-ups in a wide range of areas, including fundraising, BOD presentations, corporate communications, in-licensing, collaborations, legal matters and operations and facilities.New Product Planning Expertise:- Indication Strategy- Preclinical R&D Strategy- Clinical R&D Strategy- Corporate Strategy- Target Product Profiles- Market Research and Insight- Competitive Intelligence- Key Opinion Leader Relationships and Insight- Business Development Assessments- Collaboration with External PartnersTherapeutic Area Expertise:- Immuno-oncology (Breast, Bladder, Colorectal, Head and Neck, Melanoma, Mesothelioma, Pancreatic and Multiple Myeloma)- Nephrology (IgA Nephropathy)- Neurology (Alzheimer’s, ALS, Lysosomal Storage Disorders, Huntington’s, Pain, Spinocerebellar Ataxia, Spinal Muscular Atrophy, Others)
-
Senior Director Of Corporate StrategyGenedit Jun 2021 - PresentSouth San Francisco, California, UsI am the only Director-level executive on the leadership team and I lead the strategic planning for the transition from a platform company to a therapeutic company.More specifically, I assess broad range of therapeutic areas while focusing on disorders of the nervous system. I use a bespoke framework for indication selection that I developed to match technology (delivery, target and payload) with indications (patient population, unmet needs, differentiation, clinical development and commercial potential). I work with KOLs to plan preclinical and clinical development. And I continue to assess new opportunities based on new results from ongoing R&D. -
Director Of Business Development And OperationsGenedit Nov 2019 - Jun 2021South San Francisco, California, UsI was employee #11 and I filled filled numerous functions to enable growth: co-managed facilities, HR, and finance; coordinated with outside advisors for in-licensing of IP; and reviewed contracts. I also established strategic planning, which led to a promotion and a change of responsibilities.
-
Director Of Business DevelopmentNewomics, Inc. Mar 2019 - Nov 2019Berkeley, California, UsI filled multiple roles: (1) corporate strategy for new medical device to treat age-related diseases; (2) marketing and business development for consumable product for mass spectrometry; and (3) scientific writing for the Alzheimer’s diagnostic program -
Associate Director, Market PlanningAduro Biotech May 2011 - Jan 2019My most notable accomplishment is that I was a key contributor to the initiation of a clinical trial of BION-1301 in patients with IgA nephropathy, which was a significant strategic change from immuno-oncology to nephrology. The change led to a merger with Chinook, which reported positive Phase 2 results for BION-1301 and has advanced the therapy into Phase 3. Chinook was acquired by Novartis because of “two high-value, late-stage assets in development for IgA nephropathy,” including BIO-1301 (now named zigakibart)During my tenure as Associate Director, Market Planning, I represented the Commercial group on multiple project teams. I assessed market opportunities and competition for a broad portfolio of antibodies, small molecules and cell-based therapies for cancer – particularly immuno-oncology – and autoimmune diseases. I evaluated SoC, unmet medical needs and competing therapeutics to identify potential strategic fits with putative mechanisms of action. I prepared target product profiles and high-level, preliminary revenue forecasts. In parallel, I led initial messaging development and supported medical affairs.Prior to Market Planning, I was Associate Director, Strategic Development. I provided market and competitive intelligence for the lead asset, then in Phase 2 in pancreatic cancer and Phase 1b in mesothelioma, to support commercialization plans. I covered key oncology conferences to track competition and trends. In addition, I was the liaison with outside counsel and was responsible for reviewing simple contracts (such as NDAs, MTAs, consulting agreements) and tracking all pending and completed contracts. I was also the business development analyst for acquisition and in-licensing of immuno-oncology therapeutics and intellectual property. And I was primary author on press releases and curator of the company website 2012-2013.
-
PrincipalBioperspectives Jul 2002 - May 2011The unifying theme to my work at BioPerspectives was market analysis and competitive intelligence for drug discovery and multiplexed diagnostics technologies. I performed more than 75 proprietary analyses that covered opportunity identification, competitive assessment, specification optimization, trend characterization and preliminary financial modeling. I also wrote more than 20 business plans for early-stage companies.I earned multiple honors, including being featured as a Proteomics Pioneer in ProteoMonitor, being quoted in Science, Nature Biotechnology and Economist and being an invited speaker (with two keynote presentations) at conferences in the US, Europe and Asia.
-
Technology NavigatorBioinsights Jul 1999 - Jun 2002BioInsights was the precursor to BioPerspectives.
-
Senior Business AnalystFront Line Strategic Management Consulting Nov 1997 - Jun 1999Market analysis for therapeutics and drug discovery technologies
Steven Bodovitz Skills
Steven Bodovitz Education Details
-
Northwestern UniversityNeuroscience -
Uc San DiegoBiochemistry And Cell Biology
-
San Francisco University High School
Frequently Asked Questions about Steven Bodovitz
What company does Steven Bodovitz work for?
Steven Bodovitz works for Genedit
What is Steven Bodovitz's role at the current company?
Steven Bodovitz's current role is New Product Planning | Corporate Strategy.
What is Steven Bodovitz's email address?
Steven Bodovitz's email address is sb****@****ech.com
What is Steven Bodovitz's direct phone number?
Steven Bodovitz's direct phone number is +151084*****
What schools did Steven Bodovitz attend?
Steven Bodovitz attended Northwestern University, Uc San Diego, San Francisco University High School.
What are some of Steven Bodovitz's interests?
Steven Bodovitz has interest in Business Planning, Neuroscience, Entrepreneurship.
What skills is Steven Bodovitz known for?
Steven Bodovitz has skills like Biotechnology, Strategy, Entrepreneurship, Lifesciences, Market Research, Life Sciences, Strategic Planning, Clinical Trials, Market Analysis, Pharmaceutical Industry, Commercialization, Clinical Development.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial